Logo image
Back
Novel and Controversial Therapies in COVID-19
Journal article   Open access   Peer reviewed

Novel and Controversial Therapies in COVID-19

Romil Singh, Likhita Shaik, Ishita Mehra, Rahul Kashyap and Salim Surani
The open respiratory medicine journal, Vol.14(1), pp.79-86
12/31/2020
DOI: 10.2174/1874306402014010079
PMID: 33717367
url
https://doi.org/10.2174/1874306402014010079View
Published (Version of record) Open Access

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease (COVID-19) pandemic, which has led scientists all over the world to push for the identification of novel therapies for COVID-19. The lack of a vaccine and specific treatment has led to a surge of novel therapies and their publicity in recent times. Under these unprecedented circumstances, a myriad of drugs used for other diseases is being evaluated and repositioned to treat COVID-19 (example- Remdesivir, Baricitinib). While multiple trials for potential drugs and vaccines are ongoing, and there are many unproven remedies with little or no supporting evidence. Presently, discussions are revolving around the use of multivitamins (Vitamin, C, D, A), minerals (selenium, zinc), probiotics, flavonoids, polyphenols, and herbal remedies (curcumin, artemisinin, herbal drinks). Our review delves further into the details of some of these controversial therapies for COVID-19.
 COVID-19 Controversial therapy Pneumonia Review Antioxidant Novel therapy

Details

Metrics

1 Record Views
Logo image